Alkermes plc
2024 Annual General Meeting

PROXY MATERIALS

Annual Report

Annual Report
to Shareholders

Proxy Statement

Proxy Statement and Notice of
Annual General Meeting

VOTE

Your vote is IMPORTANT!

Please vote your proxy online now using the below button or by phone by dialing 866-813-1445.

Vote Now

ANNUAL GENERAL MEETING INFORMATION


DATE AND TIME:
May 31, 2024
2:00 p.m. Irish Standard Time

LOCATION:
Alkermes plc
Connaught House, 1 Burlington Road 
Dublin 4, Ireland, D04 C5Y6 

ABOUT US

Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.

About Us